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The increase of a skin malignant melanoma (melanoma malignum) incidence in the world has been observed in recent years. The
tumour, especially in advanced stadium with metastases, is highly resistant to conventional treatment. One of the strategies is to
modulate melanogenesis using chemical compounds. In this study, the processes of diﬀerentiation and melanogenesis induced by
dimethylsulfoxide (DMSO) in human melanoma cells (A-375) were investigated. Natural melanin isolated from A-375 melanoma
cell line treated with 0.3% DMSO was analyzed by pyrolysis-gas chromatography-mass spectrometry (Py-GC/MS) method. The
products derived from pheomelanin have not been stated in the pyrolytic proﬁle of analyzed melanin. Within all products derived
fromeumelanins,1,2-benzenediolhasbeenpredominated.Ithasbeenshownthatinthemelanomacellsstimulatedwith0.3%and
1% DMSO, the increase of transcriptional activity of the tyrosinase gene took place. It was accompanied by the rise of tyrosinase
activity and an accumulation of melanin in the cells. The better knowledge about the structure of melanins can contribute to
establish the uniform criteria of malignant melanoma morbidity risk.
1.Introduction
In recent years, the increase of a skin malignant melanoma
(melanoma malignum) incidence in the world has been
observed. Though this type of carcinoma comprises just 5%
of all malignant skin cancers, it is also responsible for 75–
80%ofdeathscausedbythesetumors.Thehighestmorbidity
rate of this cancer was noted in Australia (40–60/100000), in
the United States of America (10–20/100000), and in Europe
(10–15/100000) [1, 2].
The morbidity rate of skin melanoma malignum in
Poland, according to the National Registry of Cancer,
amounted 4.4/100000 and 5.1/100000 in 2002, for men and
women, respectively. It was observed that the amount of
new cases of the melanoma in Poland from 1982 to 2002
increased 3 times and the rate of death in the same period
increasedover2times,whatwasattestedtoabettereﬃciency
of therapy of this cancer in recent years [3].
The high morbidity rate is also associated with rapidly
growing mortality rate. The malignant melanoma at higher
stages of malignancy is highly resistant to conventional
treatment. Therefore, there is a demand for the development
of alternative antitumor therapies and better understanding
ofthemechanisms responsibleforthemalignantphenotypes
[4].
Melanoma malignum is one of the most malignant and at
the same time the most frequently occurring aggressive skin
tumor, the origin of which is the malignant transformation
of melanocytes, cells which produce the melanin pigment [4,
5]. Melanocytes of mammals produce two types of melanin2 The Scientiﬁc World Journal
pigments, the black to brown eumelanin and the yellow to
reddish pheomelanin [6–9].
In contrast to other biopolymers such as proteins or
nucleic acids, melanin is characterized by the presence of
nonhydrolyzable carbon-carbon bonds linking its mono-
mers. This fact makes diﬃcult to elucidate melanin structure
due to the lack of eﬀective analytical methods [10, 11].
As yet, the mechanisms regulating the pathogenesis of
melanoma malignum have not been fully elucidated. It
has not been established which exogenous (e.g., UV) or
endogenous(genetic)factorsplayakeyroleinthemelanoma
etiopathogenesis.However,itiswellknownthatmelanomais
a highly metabolically active tumor that produces numerous
substances recognized as neoplastic markers (e.g., cytokines,
growth factors, apoptotic factors) used in laboratory diag-
nostics. The markers used for the detection of melanoma
cells included some antigenic proteins as well as precursors
and metabolites of melanin (assayed in serum and urine)
[12].
The synthesis and accumulation of the melanins in
the malignant melanoma cells are essential factors which
determinate the eﬃcacy of therapy. There are diﬀerent
opinions about the role of melanins in melanoma malignum
etiopathogenesis. On the one hand, the presence of melanins
can cause the negative eﬀects in malignant cells. Firstly,
melanins can bind some cancer medicines (including cyto-
static drugs) and, in this way, reduce the eﬃciency of
chemotherapy. Secondly, the excess of melanins can lead
to hypoxia and reduction of the eﬃciency of radiother-
apy. Moreover, indirect products of melanogenesis and the
products arising as a result of melanins degradation are
all cytotoxic. The cytotoxicity, instead of inhibiting the
developmentofmalignantcells,canturnagainsttheimmune
system cells [4].
On the other hand, melanogenesis is the marker of
melanocytes’ diﬀerentiation, which is the opposite process to
carcinogenesis [13]. One of the chemical compounds, which
can suppress the proliferation and induce the diﬀerentiation
of malignant cells in vitro, is dimethyl sulfoxide (DMSO).
This highly polar organic liquid is often used as a chemical
solvent.Italsoshowsarangeofpharmacologicalactivity,like
anti-inﬂammatory properties. DMSO induces melanogene-
sis and diﬀerentiation of HO melanoma cell line. However,
it does not induce the dendrite-like structures in malignant
cells [14].
In the present study, we developed an experimental
model useful for investigations of factors controlling the
processes of diﬀerentiation and melanogenesis in human
melanoma cells. DMSO was used as a model compound
stimulating diﬀerentiation and melanin synthesis in human
A375 cell line.
The aim of the study was to characterize the chemical
structure of melanin isolated from DMSO-treated human
melanoma cells (A-375), using pyrolysis-gas chromatogra-
phy/massspectrometry(Py-GC/MS).Inthefuture,structure
elucidation of melanin pigments isolated from melanoma
malignum may be helpful in the establishment of criteria for
prediction of the risk of melanoma skin cancer.
2. Experimental
2.1. Materials
2.1.1. Tumor Cells. The human malignant melanoma cell
lineA-375waspurchasedfromLGCPromochem(Lomianki,
Poland). Malignant cell line was grown in the medium
containing the following composition: 90% Minimum
Essential Medium Eagle (MEM, Sigma-Aldrich), 10% fetal
bovine serum (FBS, PAA), 100U/mL penicillin, 100µg/mL
streptomycin (Sigma-Aldrich), and 10mM HEPES (Sigma-
Aldrich). The cell culture was cultivated in the standard
conditions: temperature was 37◦C, and atmosphere was con-
taining 95% air and 5% CO2. To study the cell proliferation,
melanocytes were plated at an initial density of 103 cells per
wellin200µLofculturemediumin96-wellplates.Cellswere
allowed to attach and grow for 24h prior to exposure to test
reagents. Cells were incubated with DMSO for 72h.
2.1.2. Melanin Isolation from A-375 Melanoma Cells. 1gof
melanoma cells (A-375 cell line) was mixed with 5mL of 1%
Triton X-100 (Sigma) and incubated for 1h at room tem-
perature [15]. Next the sample was centrifuged (10000×g,
15min),andthecellpelletwaswashedwithphosphatebuﬀer
and once again centrifuged. The pellet was mixed with 5mL
of (5mg/mL) sodium dodecyl sulfate (SDS) in Tris-HCl
buﬀer (50mM, pH = 7.4) with proteinase K (Sigma) to
the ﬁnal solution of 0.33mg/mL. The mixture was incubated
for 3h in 37◦C. After centrifugation (10000×g, 15min), the
melanin pigment was successively washed with 0.9% NaCl,
methanol,andhexaneandeverytimecentrifuged(10000×g,
15min). The melanin was dried at 37◦C and stored in glass
desiccator over P2O5.
2.1.3. Synthesis of Melanin from Tyrosine Catalyzed by Tyrosi-
nase (Tyr-Melanin). 0.004g tyrosine hydrochloride (Sigma)
was dissolved in 50mL sodium phosphate buﬀer (pH
6.8), then tyrosinase 100U/mL (Sigma, 5370U/mg) was
added, and the reaction mixtures were incubated for 48h
at 37◦C with vigorous stirring and protection from light.
The obtained Tyr-melanin pigment formed was collected by
centrifugation (5000×g, 10min) and washed several times
withdeionizedwater.Toremovepossibletracesoftyrosinase,
Tyr-melanin standard was treated with SDS and methanol,
NaCl, then rewashed with deionized water, and dried to a
constant weight at 37◦C.
2.2. Methods
2.2.1. Tyrosinase Activity Assay. The tyrosinase activity was
assayed by the method of Slominski et al. [16]. A-375 cells
were seeded in 100mm culture dishes at a density of 1×106
cells/dish in 12mL of above-mentioned medium. The cells
were allowed to attach and grow for 24h. Subsequently,
the culture medium was changed and the cells were treated
with 0.3% and 1% DMSO for 3 and 7 days. At the end
of the incubation periods, cells were washed with PBS and
collected by trypsinization. Detached cells were centrifugedThe Scientiﬁc World Journal 3
at 4000g for 5min. Subsequently, the cell pellet was lysed
in 1% Triton X-100 (Sigma) in 0.1M phosphate buﬀer
(pH 6.8) for 30min. Lysate was incubated with an equal
volume of DOPA (3mg/mL in 0.1M phosphate buﬀer pH
6.8) for 3h at 37◦C and the absorbance was measured
at 490nm (spectrophotometer Hewlett Packard 8452A).
The stimulation of tyrosinase activity following the DMSO
treatment was estimated as fold increase in treated cells with
respect to vehicle-treated control cells.
2.2.2. Tyrosinase Expression (RT-PCR). A-375 cells were
seeded and treated as it was described previously. The tran-
scriptionalactivityoftyrosinasegenewasdeterminedusinga
real-time RT-PCR technique. Total RNA was extracted from
A-375 cells treated with DMSO for 3 and 7 days. RNA was
extracted with NucleoSpin RNA II Kit (Macherey-Nagel)
according to the manufacturer’s instructions.
All RNA samples were treated with DNase I (Macherey-
Nagel). The RNA concentration was determined using
Quant-iT RiboGreen RNA Assay Kit (Invitrogen) accord-
ing to the manufacturer’s instructions. The primers for
PCR ampliﬁcation of tyrosinase transcript were designed
using Primer Express 2.0 software on a sequence attained
from GenBank (ref. no U01873). Primer sequences were
as follows: TF 5 -CTTCGATTTGAGTGCCCCAGA-3  and
TR 5 -CCAAGCAGTGCATCCATTGAC-3 .G l y c e r a l d e h y d e -
3-phosphate dehydrogenase (GAPDH) RNA was used as
an endogenous control. GAPDH primer pair was as fol-
lows: GF 5 -GAAGGTGAAGGTCGGAGTC-3  a n dG R5  -
GAAGATGGTGATGGGATTTC-3  [17].
The reverse transcription and ampliﬁcation reactions
were performed by use of the Power SYBR Green RNA-to-
CT 1-Step Kit (Invitrogen). The reaction was performed in
av o l u m eo f2 0 µL, containing 50ng of RNA and 0,2µM
primers. The cycle parameters were as follows: 30min at
48◦C, 10min at 95◦Cf o l l o w e db y4 0c y c l e so f1 5 sa t
95◦C ,3 0sa t5 4 ◦C, and 30s at 72◦C. Under these reaction
conditions, the ampliﬁcation eﬃciencies were between 95
and 100%. The speciﬁcity of PCR reaction was conﬁrmed
by melting curve analysis and by the use of electrophoresis
on 2% agarose gels, stained with ethidium bromide. The
threshold cycle (Ct) values were used to determine the
relative expression ratios between the controlled and treated
cells. The relative expression calculations and statistical
analyses were performed using the REST 2009 software [18].
Real-time RT-PCR was run in triplicate for both genes in
each sample.
2.2.3. Py-GC/MS of Melanin. Melanin samples were placed
on the tips of ferromagnetic wires and inserted immediately
into a Curie Point pyrolyser (type 795050, Pye-Unicam),
coupled directly to a gas chromatograph (5890 Series II,
Hewlett-Packard), and interfaced with a mass spectrometer
(5989A, Hewlett-Packard). The pyrolysis (thermolysis) was
carried out at 770◦C for 8s. The pyrolysis cell was kept at
220◦C. GC separations of the products formed were per-
formed on Rtx-5MS (Restek) fused-silica capillary column
(5% diphenyl, 95% dimethyl polysiloxane, 60m × 0.32mm
i.d., 0.5µm ﬁlm thickness). The GC column outlet was
connected directly to the ion source of a mass spectrometer.
The GC/MS interface was kept at 250◦C. Helium was used as
the carrier gas at a ﬂow rate of 1.8mL/min. The GC oven
temperature was programmed from 40◦C (isothermal for
5min) to 220◦Ca tar a t eo f1 0 ◦C/min; the ﬁnal temperature
was held for 15min. The MS conditions were as follows:
electron energy, 70eV; ion source temperature, 200◦C; and
quadrupole analyzer temperature, 100◦C. All the mass spec-
tra were recorded at m/z 25–200 (0–5min) and m/z 33–500
(above 5min). A Hewlett-Packard, ChemStation G1034C
version C.02.00 software was used for data collection and
mass spectra processing. The mass spectra of the thermolysis
products obtained were compared with standard spectra of
the Wiley Registry of Mass Spectral Data 8th Edition.
3. Results and Discussion
It is now well known that changes in the histone acetylation
levelsareinvolvedinmelanomapathogenesis.Especially,his-
tone hypoacetylation inﬂuences the transcriptional activity
of numerous genes controlling cell cycle progression, cell
signaling, diﬀerentiation, DNA repair, apoptosis, invasion,
and immune response. The acetylation reaction is catalyzed
by the histone acetyltransferase (HAT) and the opposite
process—deacetylation—is catalyzed by histone deacetylases
(HDACs). Histone deacetylase inhibitors (HDACis) inhibit
cell proliferation and induce apoptosis in numerous neo-
plastic cell lines. They are considered as a class of new
promising antineoplastic drugs, possessing chemopreventive
potential. So far, clinical studies were performed with the
some HDACis, for example, valproic acid, FR901228, MS-
275, and SAHA [19]. DMSO is also HDAC inhibitor and
hence it inﬂuences on proliferation and diﬀerentiation of
various cancer cell lines.
Dimethyl sulfoxide is one of the factors, which can
induce the melanogenesis. DMSO and the other factor, 6,7-
dimethoxycoumarin, can induce melanogenesis even with-
out increased tyrosine concentration in the culture medium
[20, 21]. Similar eﬀects were obtained in the experiment
performed by Huberman and coworkers, where human
malignant melanoma cell line HO was exposed to DMSO
at concentrations of 0.5%–2%. The authors have also shown
that DMSO at concentrations of 1.5% and 2% signiﬁcantly
inhibited proliferation of malignant cells [13]. It has been
conﬁrmed during our preliminary experiments that DMSO
at concentrations of 3% and 10% has signiﬁcantly decreased
the proliferation of A-375 cell line and exerted strong
cytotoxic eﬀect (data not shown). We have also found
that DMSO in concentrations of 0.3% and 1% did not
signiﬁcantly inﬂuence on the A375 cells growth.
IthasbeenprovedthatDMSOcaninducethediﬀerentia-
tionofpinealcellsof8-dayembryonicquail.Thosecellshave
ability to transform into skeletal muscle ﬁbers, pigmented
epithelial cells, lens cells, and neurons. Melanogenesis is
one of the earliest markers of multipotential pineal cells
diﬀerentiation. In 8-day pineal, three levels of diﬀerentiation
are observed. The ﬁrst level includes melanin and tyrosinase;
the second owns tyrosinase without pigment. Third level4 The Scientiﬁc World Journal
is tyrosinase-negative. DMSO transforms pineal cells into
pigment cells including all 3 levels [22].
In this study, melanogenesis was evaluated by determi-
nation of tyrosinase activity, the key enzyme of this process
[23, 24]. The tyrosinase catalyzes the hydroxylation of L-
tyrosine to 3,4-dihydroxyphenylalanine (L-DOPA) followed
by the oxidation of L-DOPA to dopaquinone [6, 7]. Our
results indicated that after 3 days of incubation of cells
with DMSO at the concentrations of 0.3% and 1%, the
tyrosinase activity was increased 1.09- and 1.35-fold over
control, respectively, whereas after the 7 days of incubation
the activity of this enzyme increased 1.17- and 1.37-fold
for 0.3% and 1% DMSO treated cells, correspondingly
(Figure 1), leading to an augmentation of melanogenesis
process. Melanin accumulation in cells treated with DMSO
waspreviouslydemonstratedbyHubermanetal.andSirack´ y
et al. [14, 20].
The tyrosinase transcript levels in A-375 cells were
assessed using real-time PCR technique. Treatment of cells
with 0.3% and 1% DMSO for 3 days resulted in a large
increase of transcriptional activity of the tyrosinase gene
(Figure 2(a)). However, after the extension of the incubation
period to 7 days, levels of tyrosinase mRNA dropped below
the control value (Figure 2(b)). This indicates that the
augmentation of transcriptional activity of tyrosinase gene
after DMSO treatment has a temporary character. It is
followed by a reduction of the tyrosinase gene expression,
presumably as a result of the negative feedback regulation.
These results are in concordance with ﬁndings of Riley
[4], who stated that increased melanogenesis with over-
expression of tyrosinase in malignant melanoma was asso-
ciated with defective melanosomes.
Although we observed only moderate increases of tyrosi-
nase activity after treatment of A-375 cells with DMSO,
a considerable accumulation of melanin took place in the
treated melanocytes. We were not able to isolate melanin
from untreated cells, whereas isolation eﬃciency of 4.9mg/g
was achieved after treatment of cells with 0.3% DMSO for 7
days. Similar response of that cell line was observed by Ale-
siani et al. [25] after exposition to 5,7-dimethoxycoumarin.
The authors found ﬁvefold increase in the melanin con-
tent within the cells after treatment with 500µM5 , 7 -
dimethoxycoumarin, whereas tyrosinase activity was ele-
vated 1.23-fold.
The melanin isolated from A-375 cells treated with 0.3%
DMSO has been analyzed by use of Py-GC/MS technique.
It can be noticed that the main pyrolysis product was 1,2-
benzenediol. The other detected products were: benzene,
pyrrole, pyridine, phenol, indole, and their methyl deriva-
tives. These compounds are considered to be the most
characteristic products of thermal degradation of eumelanin
[26, 27].
Ste ¸pie´ n et al. [28] have shown that the pyrolytic proﬁle
of melanin isolated from human epidermal melanocytes
contained mainly compounds characteristic of eumelanins;
however, the predominant product turned out to be styrene.
The diﬀerences concerned the presence of traces of thiazole
and methylthiazole (pyrolysis products of pheomelanin) in
the pyrolysates of melanin from epidermal melanocytes.
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Figure 1: The eﬀect of 0.3% and 1% DMSO on tyrosinase activity
inA-375melanomacellsculturedby3or7days.Eachbarrepresents
the mean ± SD; C: control.
We have not detected any marker products of thermal
degradation of pheomelanin in the pyrolysate of natural
melanin from A-375 cell line [29, 30]. Therefore, syn-
thetic melanin obtained as a result of enzymatic tyrosine
oxidation (Tyr-melanin) has been used as a standard of
human eumelanin pigment. Py-GC/MS analysis revealed
that pyrolytic proﬁle of melanin derived from A-375 cells
treated with DMSO (Figure 3(a)) was qualitatively similar to
melanin formed from tyrosine in the presence of tyrosinase
(Figure 3(b)). However, there were some diﬀerences in the
quantitative relationships between particular products of
thermal degradation of these melanins. The predominant
pyrolysis product of Tyr-melanin was pyrrole, whereas
pyrolysates of natural melanin were dominated by 1,2-
benzenediol. Relatively big amounts of phenol, toluene, and
indole were detected in pyrolysates of Tyr-melanin. It is
possible that the lower content of compounds (pyrrole,
indole, and benzene derivatives) in melanin isolated from
neoplastic A-375 cells can be helpful in discrimination of
melanins from melanoma malignum.
The melanoma cells are metabolically and produce a
lot of substances recognized as neoplastic markers (some
proteins, cytokines, melanin metabolites) that are used in
laboratory diagnostics [12, 31]. Rosso et al. [32]h a v e
reported that pyrrole-2,3,5-tricarboxylic acid (PTCA), char-
acteristicproductofeumelanindegradation,canbeareliable
marker of melanoma. 4-amino-3-hydroxy-phenylalanine (4-
AHP) and 3-amino-4-hydroxyphenylalanine (3-AHP), typ-
ical products of pheomelanin degradation, could play the
same role [33].
The obtained results indicate the lack of relationships
between the composition of products obtained as a result
of thermal degradation of melanin from A-375 cell line and
melanin markers assessed in the urine of patients suﬀering
from melanoma [33].
The elucidation of structure of melanin isolated from
melanoma malignum may be helpful to develop criteria
allowing a prediction of the risk of skin tumor.The Scientiﬁc World Journal 5
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Figure 2: The eﬀect of 0.3% and 1% DMSO on the transcriptional activity of tyrosinase gene in A-375 cells cultured by 3 (a) or 7 (b) days.
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Figure 3: Chromatogram of the products formed during pyrolysis of (a) melanin isolated from the human melanoma malignum (A-375
cell line) treated by DMSO, and (b) model synthetic eumelanin (Tyr-melanin). Peak designation: (1) acetic acid, (2) benzene, (3) pyridine,
(4) pyrrole, (5) toluene, (6) acetamide, (7) pyridine, 2-methyl-, (8) furfural, (9) pyrrole, 2-methyl-, (10) pyrrole, 3-methyl-, (11) pyridine,
4-methyl-, (12) styrene, (13) furanone, (14) cyclohexanone, (15) phenol, (16) n.i., (17) phenol, 2-methyl-, (18) phenol, 4-methyl-, (19)
1,2-benzenediol, (20) n.i., (21) 1,2-benzenediol, 4-methyl-, (22) indole, (23) 2-methoxy-4-vinylphenol, (24) indole, 3-methyl-.
4. Conclusions
Malignant melanoma is one of the most malicious tumors.
The average survival time of patients with this stage of
melanoma usually does not exceed 1 year. Chemotherapy
or immunotherapy lengthens the survival time only to
about 5 years and only in a small group of patients. In
this case, there is a need to look for the new therapeutic
and diagnostic solutions. Melanogenesis is a marker of the
melanocyte diﬀerentiation, which is an opposite process to
thecarcinogenesis.Therefore,thereisapossibilitytoevaluate
the stage of malignancy by determination of the intensity of
melanogenesis in malignant melanoma cells. In our study we
proved that DMSO induces melanogenesis in A-375 cell line,
thereby it stimulates the diﬀerentiation of melanoma cells
and increases the activity of tyrosinase enzyme. However,
this compound does not induce the formation of dendritic-
like cells (e.g., 5,7-dimethoxycoumarin). We also proved
that the predominant melanin isolated from melanoma
cells is eumelanin. The results presented in our work show
that DMSO is able to induce the diﬀerentiation of human
melanoma cells in vitro. Thereby, DMSO can be used as a6 The Scientiﬁc World Journal
research model of other HDACis, which have application in
the treatment of malignant melanoma.
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